Torreya News

July 27, 2017

Update on Torreya’s recent activity advising on M&A, capital markets and licensing transactions.  MORE

December 21, 2016

XOMA Announces up to $22 Million Generated from Sale of Royalty Streams from Two License Agreements to HealthCare Royalty Partners and Provides Corporate Update  MORE

December 15, 2016

Opiant Pharmaceuticals, Inc. Announces NARCAN Nasal Spray Royalty Monetization  MORE

October 25, 2016

Everstone Capital Invests Rs 220 Crore in Rubicon Research  MORE

August 5, 2016

IntelGenx Announces Sale of Forfivo XL(R) Royalty for $6 Million  MORE

July 11, 2016

New Mountain Capital Partners with Topix Pharmaceuticals  MORE

February 29, 2016

Hikma Announces the Close of the Roxane Laboratories Acquisition  MORE

February 1, 2016

ANI Pharmaceuticals Acquires Exclusive Rights to Distribute Three Generic Drug Products from H2-Pharma for $10 Million  MORE

December 23, 2015

Agenus Acquires PhosImmune with a Novel Class of Cancer Neoantigens  MORE

November 17, 2015

Pharma Industry Veterans Launch Vertice Pharma in Partnership with Warburg Pincus; Announce Acquisition of VistaPharm  MORE

November 5, 2015

XOMA Announces the Sale of Its Manufacturing Facilities to Agenus  MORE

November 5, 2015

XOMA divests biodefense program to Nanotherapeutics, Inc.  MORE

October 13, 2015

IGI Laboratories, Inc. Enters Into Agreement To Acquire The Assets Of Canadian Pharmaceutical Company, Alveda Pharmaceuticals, Inc.  MORE

October 1, 2015

XOMA Announces Development and Commercialization Agreement for First-in-Class Anti-TGF-beta Antibody Program in Immuno-Oncology  MORE

July 28, 2015

Merck Enhances Immuno-Oncology Portfolio with Acquisition of cCAM Biotherapeutics  MORE

July 13, 2015

ANI Pharmaceuticals Acquires 22 Generic Drug Products from Teva Pharmaceuticals for $25 million  MORE

June 9, 2015

Mission Pharmacal Acquires ProSolus Pharmaceuticals  MORE

June 4, 2015

DARA BioSciences Announces Proposed Acquisition Agreement With Midatech Pharma PLC, a UK Based Specialty Pharmaceutical Company  MORE

May 21, 2015

arGEN-X and LEO Pharma Enter into Alliance to Develop Antibody-based Treatments for Skin Conditions  MORE

May 19, 2015

Ipsen strengthens its presence in the oncology field with the acquisition of OctreoPharm Sciences, a company developing innovative radiopharmaceuticals for the diagnosis and treatment of neuroendocrine tumours  MORE

March 18, 2015

Prestium Pharma, Inc. Acquires ZONALON® (Doxepin Hydrochloride), 5% Cream; Continues to Expand its Product Portfolio  MORE

March 5, 2015

TRIANEX® 0.05%(Triamcinolone Acetonide Ointment,USP) Now Available from Promius Pharma, LLC  MORE

January 6, 2015

Gilead Sciences Announces Acquisition of Phenex Pharmaceuticals’ Development Program for Non-Alcoholic Steatohepatitis (NASH) and Other Liver Diseases  MORE

December 16, 2014

Lightlake Therapeutics Inc. Announces Licensing Deal With Adapt Pharma Limited Subsidiary  MORE

December 15, 2014

Aseptix signs global technology license with Ecolab  MORE

November 24, 2014

Flamel Technologies Sells Development and Manufacturing Facility in Pessac, France to Recipharm AB  MORE

November 3, 2014

PDI Expands Molecular Diagnostics Business with RedPath Integrated Pathology Acquisition  MORE

October 23, 2014

Probiodrug raises €22.5 million in successful Initial Public Offering and listing on Euronext Amsterdam  MORE

October 23, 2014

Medivation Inc. Licenses Clinical Stage Anti-PD-1 Immune Modulatory Monoclonal Antibody From CureTech Ltd. for Potential Applications in Oncology  MORE

October 22, 2014

DBV Technologies S.A. Announces Pricing of Global Offering  MORE

October 16, 2014

Molecular Imaging Firm Raises $15M for Global Expansion  MORE

July 17, 2014

Acquisition of Canadian Rights to Estrace from Shire  MORE

July 17, 2014

Acquisition Financing from MidCap Financial  MORE

May 19, 2014

Ventrus Biosciences to Merge With Assembly Pharmaceuticals  MORE

May 8, 2014

Lundbeck to acquire Chelsea Therapeutics  MORE

May 2, 2014

Fibrotech acquired by Shire for US$75M plus milestones  MORE

March 20, 2014

Concordia Healthcare Announces Agreement to Acquire Donnatal  MORE

February 28, 2014

Compugen Ltd. Prices Public Offering of Ordinary Shares  MORE

February 20, 2014

DenMat, the Makers of Lumineers, Acquires Substantially All Dental Assets of Zila, Inc.  MORE

February 19, 2014

Torreya Partners Announces Three Executive Promotions  MORE

November 25, 2013

Genomic Health and Almac Group Enter Exclusive In-Licensing Agreement to Develop and Commercialize Anthracycline Chemotherapy Benefit Test for High Risk Breast Cancer  MORE

November 18, 2013

Cardiome to Acquire Correvio LLC  MORE

November 14, 2013

DBV Technologies announces the completion of a 29.9m private placement with a majority placed with US investors  MORE

September 30, 2013

Stratus Media Group Enters Dermatological and Restorative Medicine Industry, Signs Merger Agreement With Two Biopharmaceutical Companies, Changes Corporate Name To Restorgenex Corporation, and Announces New Chairman and Vice Chairman  MORE

August 26, 2013

Merus Labs International Inc. Announces Factive Product Divestiture  MORE

August 20, 2013

PDI, Inc. Enters into Collaboration Agreement to Commercialize Molecular Diagnostic Tests  MORE

August 5, 2013

Compugen Announces Collaboration And License Agreement With Bayer For Antibody-Based Cancer Immunotherapies  MORE

July 18, 2013

Bausch + Lomb Acquires Option to License New Compound to Treat Dry Eye Syndrome (DES)  MORE

May 7, 2013

Shionogi Inc. Divests And Exclusively Licenses Its Pediatric Products To Concordia Pharmaceuticals Inc.  MORE

April 30, 2013

Selexis SA Sells Rights to Royalty Payments for More Than 15 Biologic Development Programs to Ligand Pharmaceuticals  MORE

March 11, 2013

Clinigen and Theravance Announce Exclusive Commercialization Agreement in the EU for VIBATIV(R) (telavancin)  MORE

January 22, 2013

Progenics Acquires Molecular Insight Pharmaceuticals to Expand Oncology-Focused Pipeline  MORE

October 1, 2012

ProStrakan Acquires Breast Cancer Product for the US  MORE

August 27, 2012

Merz, Inc. Announces the Acquisition of CUVPOSA® (glycopyrrolate) Oral Solution, First and Only FDA-Approved Treatment for Pediatric Chronic Severe Drooling Associated With Neurologic Conditions  MORE

June 21, 2012

Depomed Announces Acquisition Of Zipsor® (diclofenac potassium) From Xanodyne Pharmaceuticals, Inc.  MORE

February 2, 2012

Mission Pharmacal Acquires Eletone Cream from Ferndale Healthcare, Inc.  MORE

July 15, 2011

NeoStem to acquire Amorcyte  MORE

July 14, 2011

Ventrus Biosciences Announces Pricing of Its Underwritten Registered Offering of Common Stock  MORE

May 27, 2011

Pharmascience Acquires Aegera Therapeutics  MORE

April 26, 2011

Cynapsus Announces Proposed Acquisition of Adagio Pharmaceuticals and Private Placement  MORE

April 4, 2011

Royalty Pharma Acquires Lexiscan® and Cubicin® Royalties for $487 Million  MORE

December 20, 2010

Lpath Grants Pfizer Exclusive Option for Worldwide License for iSONEP  MORE

October 25, 2010

Kadmon Pharmaceuticals Acquires Three Rivers Pharmaceuticals  MORE

July 30, 2010

UCB to out-license six established products to Actient Pharmaceuticals, LLC  MORE

July 2, 2010

Watson Completes Acquisition of CRINONE(R) and PROCHIEVE(R) Product Line and Shares of Columbia Laboratories  MORE

July 1, 2010

Euthymics Bioscience, Inc. and DOV Pharmaceutical, Inc. Announce Merger Agreement  MORE

June 23, 2010

Thorne Research Announces Combination with Diversified Natural Products  MORE